Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.
Cure My Disease
Don't miss your cure!
Clinical trials sponsored by Sandoz, explained in plain language.
This study tests whether CYB704, a proposed biosimilar to the approved drug Ocrevus, works just as well for people with relapsing multiple sclerosis (MS). About 175 adults with relapsing MS will receive either CYB704 or Ocrevus, and researchers will compare how the drug moves thr…
Phase: PHASE3 • Sponsor: Sandoz • Aim: Disease control
Last updated May 26, 2026 04:37 UTC